The Centre, which cost £4 million, has been jointly funded by the Northwest Regional Development Agency (NWDA) and the European Regional Development Fund (ERDF). The Nowgen project is a collaboration between the Central Manchester & Manchester Children’s University Hospitals NHS Trust and the Universities of Manchester, Liverpool and Lancaster.
Genetics knowledge has already benefited many thousands of families with inherited conditions and is set to change the way healthcare is delivered in the future; influencing, for example, how cancer and heart disease are treated.
Since its creation in 2003, Nowgen has attracted over £7 million additional world-class research investment to the North West, and partnerships have been established with other internationally renowned research centres in Europe and North America. Now that it is housed in first class facilities, it is set to deliver the objectives of the Government’s 2003 Genetics White Paper ‘Our Inheritance, Our Future’.
The White Paper aims to set out a vision of how patients could benefit in future from advances in genetics, and raise awareness of the potential of genetics in healthcare. As patient input is integral to Nowgen’s work, the Centre has launched an innovative programme of activities to engage the public through debates, arts and drama (450 school students and their teachers have already taken part in workshops at the Centre).
Key Nowgen projects include research to understand the public’s hopes and concerns about genetic tests and technologies, the education of healthcare professionals and the first NHS trial of a genetic test to predict responses to medicines.
The launch will allow guests from the healthcare, business and academic sectors to meet researchers and patient groups involved in the projects, and drama students from Prestwich Community High School will perform a short play they have written themselves about a genetic issue.
Professor Dian Donnai CBE, Nowgen’s Executive Director and Professor of Medical Genetics at The University of Manchester said ‘‘ I would like to pay tribute to the Northwest Regional Development Agency and the European Regional Development Fund for their vision in enabling the region to play a leading role in the UK’s Genetics Agenda.’’
Dr John Stageman, who is also a member of the North West Science Council, said: “I very much support this initiative which provides a unique link between business, universities and the health services and also ensures the public voice on genetic opportunities can be heard.”
Dr Linda Magee, NWDA Biotechnology Sector Director and Head of Bionow, said: “The NWDA is delighted to support this innovative centre, which will significantly boost the North West’s strength in genetics education and research, ultimately improving human health and wellbeing. It is a major asset to the region and the North West’s biomedical sector which is already worth £3.4 billion to the regional economy.”
Jo Nightingale | alfa
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Health and Medicine
06.12.2016 | Life Sciences
05.12.2016 | Power and Electrical Engineering